Spruce Biosciences, Inc. (SPRB) Tops Q2 EPS by 10c

Spruce Biosciences, Inc. (NASDAQ: SPRB) reported Q2 EPS of ($0.22), $0.10 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $1.61 million versus the consensus estimate of $1.5 million.

For earnings history and earnings-related data on Spruce Biosciences, Inc. (SPRB) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Home Depot (HD) call put ratio 1.5 calls to 1 put with a focus on September 330 puts into quarter results
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c